US Nuclear Corp (OTC: UCLE) has filed its Form 10-Q for the first quarter of 2026, revealing a 72% reduction in loss from operations compared to the same period in 2025. The company reported a decrease of over $375,000 in operating loss, signaling a significant turnaround in its financial performance. The filing, available on the SEC's EDGAR system, comes after delays in the company's 2025 annual report and subsequent quarterly filings, which have now been largely resolved.
According to Michael Hastings, CFO of US Nuclear, the delays stemmed from the closure of the company's Los Angeles operation, which led to the loss of key personnel and difficulties in retrieving financial data. Additionally, the company replaced some staff at its Overhoff subsidiary and implemented recommendations from a new auditor. "The first quarter financial close and review process took about 4 months, far exceeding the 45-day window from close of period," Hastings explained. "But things are finally falling into place, and we are committed to making the reporting process faster and more efficient."
The company expects to file its second-quarter report within the next three to four weeks and projects that its stock will resume trading after the release of the third-quarter results, anticipated around the first week of December. This resumption is critical for shareholders, as the delays had halted trading, impacting liquidity and investor confidence. The timely release of financials is expected to restore normal market activity and provide transparency into the company's progress.
Operationally, US Nuclear has taken several steps that management believes will drive a record year in 2027. In June, the company hired a General Manager/COO who is streamlining logistics, clearing backlogs, and accelerating product delivery, thereby improving the working capital cycle. The company's backlog has grown to $1.2 million and is projected to reach $2.9 million by year-end. Furthermore, US Nuclear is interviewing outsourced CPA firms to enhance financial reporting accuracy and timeliness, with onboarding expected imminently.
The company is also focusing on revitalizing its TA/Optron product line, which was previously manufactured in Los Angeles. A team of four college interns, under the GM's direction, is conducting a full marketing and product analysis to prepare for a relaunch in January 2027, with the goal of adding $600,000 in revenues that year. Additionally, US Nuclear has initiated discussions with other companies regarding potential joint ventures, a sale of the company, or a reverse merger to go public. These strategic options could significantly accelerate growth if a transaction is completed in 2027.
Management projects sales and profits to increase 20-30% in 2027 and for sales to double by 2028, or possibly higher if a deal materializes. Investors can review the detailed financials in the company's US Nuclear Form 10Q_March 31, 2026, and the annual report is also accessible via the US Nuclear Form 10K_December 31, 2025. The original press release is available on www.newmediawire.com.
